SCROLL
TOP
KINE SCIENCES DISCOVERS
AND DEVELOPS
BEYOND
THE LIMITS OF HUMAN
KINE SCIENCES DISCOVERS
AND DEVELOPS
BEYOND
THE LIMITS OF HUMAN
KINE SCIENCES DISCOVERS
AND DEVELOPS
BEYOND
THE LIMITS OF HUMAN
R&D
면역질환본부
Treg, Th2, Th17, NK 등 immune cell 조절 메커니즘을 통한 치료원리
신경질환본부
DDS, Dietary supplement, Cosmeceutical, Diagnosis 각 분야 활용 가능 원리
면역질환본부
Treg, Th2, Th17, NK 등 immune cell 조절 메커니즘을 통한 치료원리
신경질환본부
DDS, Dietary supplement, Cosmeceutical, Diagnosis 각 분야 활용 가능 원리
PIPELINE
PIPELINE
Detail
Autoimmune
Rheumatoid Arthritis (RA)
KINE-101A
Inflammatory Bowel Disease (IBD)
KINE-101B
PNS
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
KINE-101C
Metabolite
Non-Alcoholic Steatohepatitis (NASH)
KINE-101D
Dermatology
Atopic dermatitis
KINE-201A
Respiratory
Asthma
KINE-201B
Chronic Obstructive Pulmonary Disease (COPD)
KINE-201C
Dermatology
Psoriasis
KINE-301A
Cancer
Solid tumor
KINE-401A
CNS
Alzheimer's disease
KINE-501A
Frontotemporal Dementia (FTD)
KINE-501B
Lewy Body Dementia (LBD)
KINE-501C
Parkinson's disease
KINE-501D
Other
Wound healing
KINE-601A
Alopecia
KINE-601B
Autoimmune
Rheumatoid Arthritis (RA)
KINE-101A
Inflammatory Bowel Disease (IBD)
KINE-101B
PNS
Chronic Inflammatory Demyelinating
Polyradiculoneuropathy (CIDP)
KINE-101C
Metabolite
Non-Alcoholic Steatohepatitis (NASH)
KINE-101D
Dermatology
Atopic dermatitis
KINE-201A
Respiratory
Asthma
KINE-201B
Chronic Obstructive Pulmonary Disease (COPD)
KINE-201C
Dermatology
Psoriasis
KINE-301A
Cancer
Solid tumor
KINE-401A
CNS
Alzheimer's disease
KINE-501A
Frontotemporal Dementia (FTD)
KINE-501B
Lewy Body Dementia (LBD)
KINE-501C
Parkinson's disease
KINE-501D
Other
Wound healing
KINE-601A
Alopecia
KINE-601B
News & Notice
카인사이언스에서
알려드립니다.

카인사이언스의 새로운 소식과
정보를 만나보세요.

NOTICE
외부감사인 지정 공고
2024.10.08
more view
NEWS
[GROUND] First Patient Dosed in Trial of KINE-101 for CIDP
2024.09.25
more view
NEWS
[First Word PHARMA] Kine Sciences Announces First Patient Dosed in the Phase 1b/..
2024.09.25
more view
NEWS
[THE FREE LIBRARY] Kine Sciences reports first patient dosed in KINE-101 Phase 1..
2024.09.25
more view
NEWS
[Tech Dogs] Kine Sciences Announces First Patient Dosed In The Phase 1B/2A Study..
2024.09.25
more view
NEWS
[Rare Disease ADVISOR] First Patient Dosed in Trial of KINE-101 for CIDP
2024.09.25
more view
CAREER
카인사이언스와 함께
당신의 경력 혁신이 지금 시작됩니다.

카인사이언스와 함께 보다 풍요로운 미래를 만들어 갈 여러분을 기다립니다.